ArticleInternational journal of molecular sciences2023

Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma.

Hang-Seok Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.